BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28325894)

  • 1. SUMOylation and calcium control syntaxin-1A and secretagogin sequestration by tomosyn to regulate insulin exocytosis in human ß cells.
    Ferdaoussi M; Fu J; Dai X; Manning Fox JE; Suzuki K; Smith N; Plummer G; MacDonald PE
    Sci Rep; 2017 Mar; 7(1):248. PubMed ID: 28325894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tomosyn-1 is involved in a post-docking event required for pancreatic beta-cell exocytosis.
    Cheviet S; Bezzi P; Ivarsson R; Renström E; Viertl D; Kasas S; Catsicas S; Regazzi R
    J Cell Sci; 2006 Jul; 119(Pt 14):2912-20. PubMed ID: 16787939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tomosyn is expressed in beta-cells and negatively regulates insulin exocytosis.
    Zhang W; Lilja L; Mandic SA; Gromada J; Smidt K; Janson J; Takai Y; Bark C; Berggren PO; Meister B
    Diabetes; 2006 Mar; 55(3):574-81. PubMed ID: 16505218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.
    Dai XQ; Plummer G; Casimir M; Kang Y; Hajmrle C; Gaisano HY; Manning Fox JE; MacDonald PE
    Diabetes; 2011 Mar; 60(3):838-47. PubMed ID: 21266332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntaxin 2 Acts as Inhibitory SNARE for Insulin Granule Exocytosis.
    Zhu D; Xie L; Kang Y; Dolai S; Bondo Hansen J; Qin T; Xie H; Liang T; Rubin DC; Osborne L; Gaisano HY
    Diabetes; 2017 Apr; 66(4):948-959. PubMed ID: 28115395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential interaction of tomosyn with syntaxin and SNAP25 depends on domains in the WD40 β-propeller core and determines its inhibitory activity.
    Bielopolski N; Lam AD; Bar-On D; Sauer M; Stuenkel EL; Ashery U
    J Biol Chem; 2014 Jun; 289(24):17087-99. PubMed ID: 24782308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody inhibition of synaptosomal protein of 25 kDa (SNAP-25) and syntaxin 1 reduces rapid exocytosis in insulin-secreting cells.
    Vikman J; Ma X; Hockerman GH; Rorsman P; Eliasson L
    J Mol Endocrinol; 2006 Jun; 36(3):503-15. PubMed ID: 16720719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretagogin protects Pdx1 from proteasomal degradation to control a transcriptional program required for β cell specification.
    Malenczyk K; Szodorai E; Schnell R; Lubec G; Szabó G; Hökfelt T; Harkany T
    Mol Metab; 2018 Aug; 14():108-120. PubMed ID: 29910119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Munc18 and Syntaxin in the regulation of insulin secretion.
    Dong Y; Wan Q; Yang X; Bai L; Xu P
    Biochem Biophys Res Commun; 2007 Aug; 360(3):609-14. PubMed ID: 17617378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation and degradation of tomosyn-2 de-represses insulin secretion.
    Bhatnagar S; Soni MS; Wrighton LS; Hebert AS; Zhou AS; Paul PK; Gregg T; Rabaglia ME; Keller MP; Coon JJ; Attie AD
    J Biol Chem; 2014 Sep; 289(36):25276-86. PubMed ID: 25002582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNAREing voltage-gated K+ and ATP-sensitive K+ channels: tuning beta-cell excitability with syntaxin-1A and other exocytotic proteins.
    Leung YM; Kwan EP; Ng B; Kang Y; Gaisano HY
    Endocr Rev; 2007 Oct; 28(6):653-63. PubMed ID: 17878408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion.
    Bhatnagar S; Oler AT; Rabaglia ME; Stapleton DS; Schueler KL; Truchan NA; Worzella SL; Stoehr JP; Clee SM; Yandell BS; Keller MP; Thurmond DC; Attie AD
    PLoS Genet; 2011 Oct; 7(10):e1002323. PubMed ID: 21998599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic ablation of synaptotagmin-9 alters tomosyn-1 function to increase insulin secretion from pancreatic β-cells improving glucose clearance.
    Rahman MM; Pathak A; Schueler KL; Alsharif H; Michl A; Alexander J; Kim JA; Bhatnagar S
    FASEB J; 2023 Aug; 37(8):e23075. PubMed ID: 37432648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rim2alpha determines docking and priming states in insulin granule exocytosis.
    Yasuda T; Shibasaki T; Minami K; Takahashi H; Mizoguchi A; Uriu Y; Numata T; Mori Y; Miyazaki J; Miki T; Seino S
    Cell Metab; 2010 Aug; 12(2):117-29. PubMed ID: 20674857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretagogin affects insulin secretion in pancreatic β-cells by regulating actin dynamics and focal adhesion.
    Yang SY; Lee JJ; Lee JH; Lee K; Oh SH; Lim YM; Lee MS; Lee KJ
    Biochem J; 2016 Jun; 473(12):1791-803. PubMed ID: 27095850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-dependent changes in SNARE protein levels in pancreatic β-cells.
    Torrejón-Escribano B; Escoriza J; Montanya E; Blasi J
    Endocrinology; 2011 Apr; 152(4):1290-9. PubMed ID: 21285315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntaxin-4 mediates exocytosis of pre-docked and newcomer insulin granules underlying biphasic glucose-stimulated insulin secretion in human pancreatic beta cells.
    Xie L; Zhu D; Dolai S; Liang T; Qin T; Kang Y; Xie H; Huang YC; Gaisano HY
    Diabetologia; 2015 Jun; 58(6):1250-9. PubMed ID: 25762204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hydrophobic groove in secretagogin allows for alternate interactions with SNAP-25 and syntaxin-4 in endocrine tissues.
    Szodorai E; Hevesi Z; Wagner L; Hökfelt TGM; Harkany T; Schnell R
    Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2309211121. PubMed ID: 38593081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tomosyn is a novel Akt substrate mediating insulin-dependent GLUT4 exocytosis.
    Nagano K; Takeuchi H; Gao J; Mori Y; Otani T; Wang D; Hirata M
    Int J Biochem Cell Biol; 2015 May; 62():62-71. PubMed ID: 25725259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction.
    Fu J; Dai X; Plummer G; Suzuki K; Bautista A; Githaka JM; Senior L; Jensen M; Greitzer-Antes D; Manning Fox JE; Gaisano HY; Newgard CB; Touret N; MacDonald PE
    Diabetes; 2017 Jul; 66(7):1890-1900. PubMed ID: 28607108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.